Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout

Journal of Hypertension

Volumn 19, Issue 10, 2001, Pages 1855-1860

  Würzner, Grégoire ^a   Gerster, Jean Charles ^a   Chiolero, Arnaud ^a   Maillard, Marc ^a   Fallab Stubi, Claire Lise ^a   Brunner, Hans R ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiotensin II antagonists; Gout; Hypertension; Irbesartan; Losartan; Uric acid

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; IRBESARTAN; LOSARTAN; URIC ACID; URICOSURIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GOUT; HUMAN; HYPERURICEMIA; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

EID: 0034817415     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200110000-00021     Document Type: Article

References (29)

1. Serum uric acid in essential hypertension: An indicator of renal vascular involvement
2. Hyperuricemia in primary and renal hypertension
3. Hypertension and hyperuricaemia
4. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study
5. Impaired renal function gout: Its association with hypertensive vascular disease and intrinsic renal disease
6. Renal function in gout. V. Factors influencing the renal hemodynamics
7. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
8. The kidney: An unwilling accomplice in syndrome X
9. High uric acid as an indicator of cardiovascular disease. Independence from obesity
10. Serum uric acid and hypertension: The Olivetti heart study
11. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries
12. Epidemiology of gout and hyperuricemia. A long-term population study
13. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort
14. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension the PIUMA study
15. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971 -1992. National Health and Nutrition Examination Survey
16. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
17. Angiotensin II receptor antagonists
18. Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects
19. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects
20. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia
21. Effects of losartan on a background of hydrochlorothiazide in patients with hypertension
22. Effects of losartan on renal function in patients with essential hypertension
23. Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension
24. Renal effects of angiotensin II receptor blockade in normotensive subjects
25. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-bordermembrane vesicles
26. Urate transport in brush-border membrane of human kidney
27. Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients
28. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension
29. Comparative safety and tolerability of angiotensin II receptor antagonists